(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, weighs in on Bayer AG's bid for Monsanto: he's not optimistic the deal will go through.

Apple Slides Most Since 2025 After Supply Shortages Hurt Outlook
17:44

Instant Reaction: Apple Slides After Supply Shortages Hurt Its Sales Forecast
10:27

Instant Reaction: Amazon Reports Cloud Sales Growth for Fifth Straight Quarter
18:09